INDIANAPOLIS--(BUSINESS WIRE)--Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, announced the introduction of its automated radiopharmaceutical system, under the name PosiRx™, at two upcoming industry conferences. PosiRx is the commercial name for the Company’s automated radiopharmaceutical system, formerly referred to as Cardio-Assist during its developmental stage.
